Hyejo Ryu

Hyejo Ryu

Auto-generated profile, based on publicly available information

Hyejo Ryu

Department of Radiation Oncology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in Thoracic Cancer
Verified
Journal Article
Open access
HRHyejo Ryu
Hyejo Ryu
CSChanghoon Song
Changhoon Song
JKJae‐Sung Kim
Jae‐Sung Kim
JJJae Hyun Jeon
Jae Hyun Jeon
SCSukki Cho
Sukki Cho
JLJong Seok Lee
Jong Seok Lee
Background: The prognostic nutritional index (PNI) is known to be correlated with clinical outcomes in non‐small cell lung cancer (NSCLC) patients. However, its role has not been studied in patients who have undergone postoperative radiotherapy (PORT). This study aimed to investigate the relationship between PNI and survival and recurrence in NSCLC patients with PORT.Methods: We reviewed 97 stage I–III NSCLC patients who received PORT between January 2006 and December 2016 at our institution. We obtained PNI values for both pre‐RT (within 1 month before PORT) and post‐RT (within 2 months after PORT) by using serum albumin and lymphocyte count. A cutoff value for PNI was determined by the receiver operating characteristic curve (ROC). The median follow‐up period was 52.8 months.Results: The ROC curve of post‐RT PNI exhibited a higher area under the curve (AUC 0.68, cut‐off: 47.1) than that of pre‐RT PNI (AUC 0.55, cutoff: 50.3), so the group was divided into high post‐RT PNI (> 47.1) and low post‐RT PNI ( 47.1). The five‐year overall survival rate (OS) was 66.2% in the high post‐RT group, compared with 41.8% in the low post‐RT PNI group (p = 0.018). Those with both low pre‐RT and low post‐RT PNI had the worst five‐year OS of 31.1%. Post‐RT PNI (HR 0.92, p = 0.003) was an independent risk factor for mortality.Conclusions: PNI after PORT was significantly associated with survival. This finding suggests that PNI can be used as a prognostic marker.

1 June 2023 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
SCSeok-Joo Chun
Seok-Joo Chun
JPJung Bin Park
Jung Bin Park
HRHyejo Ryu
Hyejo Ryu
BJBum-Sup Jang
Bum-Sup Jang

30 December 2022 in Clinical Endocrinology
Verified
Journal Article
Open access
HRHyejo Ryu
Hyejo Ryu
HWHong‐Gyun Wu
Hong‐Gyun Wu
KLKyu Eun Lee
Kyu Eun Lee
ECEun‐Jae Chung
Eun‐Jae Chung
SASoon‐Hyun Ahn
Soon‐Hyun Ahn
HCHoon Sung Choi
Hoon Sung Choi
Objective: We evaluated the efficacy and safety of postoperative radiotherapy (PORT) for differentiated thyroid cancer (DTC) with high risk features.Materials and Methods: This retrospective study analyzed 187 patients treated for DTC from 1985 to 2019. DTC referred to nonanaplastic thyroid cancer originating from follicular cells. PORT was defined as the administration of external beam radiation to the thyroid and regional lymph nodes following surgery for initially diagnosed DTC. The patients were included in the analysis if they received PORT or exhibited any of the following features: (a) pT4 or pN1b according to the 8th American Joint Committee on Cancer, (b) poorly differentiated thyroid cancer (PDTC), or (c) unfavourable variants such as anaplastic foci and etc. After 1:1 propensity matching, a total of 108 patients were analyzed according to PORT receipt. The median follow‐up duration of the matched group was 10.4 years.Results: After matching, most of the variables became balanced, but the PORT group still had more PDTC and DTC with anaplastic foci. Radioactive iodine (RAI) was less frequently administered in the PORT group. PORT yielded a significantly higher 5‐year locoregional recurrence free survival (LRFS) than the No PORT group (5‐year LRFS 86.1% vs. 72.7%, p = 0.022), but the 10‐year cancer specific survival (CSS) was similar between them (97.8% vs. 85.9%, p = 0.122). The multivariable analysis indicated that PORT was a favourable prognostic factor (Hazard ratio 0.3, 95% Confidence interval 0.1–0.8, p = 0.02) for LRFS, but not for CSS. Among 133 patients without PORT for initial disease, 39 of them received salvage surgery followed by salvage PORT. No severe toxicity after PORT was reported.Conclusion: PORT reduced locoregional recurrence in DTC patients without severe toxicity. PORT can be an effective and safe treatment to improve locoregional control in DTC with high risk features. However, further study is warranted to identify those who can benefit from PORT.

30 September 2024 in Progress in Medical Physics
Verified
Journal Article
Open access
PDF file
SKSeonghee Kang
Seonghee Kang
HRHyejo Ryu
Hyejo Ryu
DODo Hoon Oh
Do Hoon Oh
LYLee Yoo
Lee Yoo
MCMinsoo Chun
Minsoo Chun
Seonghee Kang, Hyejo Ryu, Do Hoon Oh , Lee Yoo, Minsoo Chun. Progress in Medical Physics 2024;35:65-72. https://doi.org/10.14316/pmp.2024.35.3.65

30 September 2025 in Progress in Medical Physics
Verified
Journal Article
Open access
PDF file
YKYoohyeon Kim
Yoohyeon Kim
HPHyojun Park
Hyojun Park
HRHyejo Ryu
Hyejo Ryu
DODo Hoon Oh
Do Hoon Oh
MCMinsoo Chun
Minsoo Chun
Yoohyeon Kim, Hyojun Park, Hyejo Ryu, Do Hoon Oh, Minsoo Chun. Progress in Medical Physics 2025;36:45-51. https://doi.org/10.14316/pmp.2025.36.3.45

30 September 2025 in Progress in Medical Physics
Verified
Journal Article
Open access
PDF file
HPHyojun Park
Hyojun Park
YKYoohyeon Kim
Yoohyeon Kim
LYLee Yoo
Lee Yoo
HRHyejo Ryu
Hyejo Ryu
DODo Hoon Oh
Do Hoon Oh
MCMinsoo Chun
Minsoo Chun
Hyojun Park, Yoohyeon Kim, Lee Yoo, Hyejo Ryu, Do Hoon Oh, Minsoo Chun. Progress in Medical Physics 2025;36:52-60. https://doi.org/10.14316/pmp.2025.36.3.52